Cernay-la-Ville, France

Alain Croisy


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alain Croisy: Innovator in Photodynamic Therapy

Introduction

Alain Croisy is a notable inventor based in Cernay-la-Ville, France. He has made significant contributions to the field of photodynamic therapy through his innovative research and development of porphyrin derivatives. His work focuses on creating compounds that can effectively target and impair biological materials, such as viruses and tumoral cells.

Latest Patents

Alain Croisy holds a patent for "Porphyrin derivatives for photodynamic therapy." This invention pertains to porphyrin compounds that are utilized to destroy or impair the functioning of target biological materials in photodynamic therapy. The invention is particularly effective against viruses, tumoral cells, bacteria, and tumorous tissues. Additionally, it includes compositions containing these compounds and a method for photosensitizing and destroying or impairing the functioning of such target biological materials in vitro.

Career Highlights

Throughout his career, Alain Croisy has worked with prestigious institutions, including the Institut Curie and the Centre National de La Recherche Scientifique. His experience in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Alain Croisy has collaborated with notable professionals in his field, including David Grierson and Philippe Maillard. These collaborations have further enriched his research and development efforts.

Conclusion

Alain Croisy's innovative work in photodynamic therapy exemplifies the impact of scientific research on medical advancements. His contributions through patents and collaborations continue to influence the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…